Occupational Activity

Dr Melanie Ivarsson Appointed CEO of Health Data Research Service

3 days ago talkbio0Tagged Appointments, Barakat syndrome, CEO, health data, Health Data Research Service, Medical Research activity, Melanie Ivarsson, UK

Dr Melanie Ivarsson; Health Data Research Service; HDRS; CEO appointment; UK health data; medical research

Argenx Appoints Karen Massey as New CEO in Leadership Transition

1 week ago talkbio0Tagged Argenx, CEO, Infrequent, Karen Massey, Leadership, Tim Van Hauwermeiren, Transition Mutation

argenx; Karen Massey; CEO; Tim Van Hauwermeiren; leadership transition; rare diseases; Vyvgart

FDA Clears BrainSpace Intellidrop: Automated Neuro Device Tackling ICU Nursing Shortages and Advancing Physical AI

2 weeks ago talkbio0Tagged Administration occupational activities, brain fluid, BrainSpace, Clearance, ICU, ICU nursing shortages, Intellidrop, neuro injury, Physical AI, United States Food and Drug Administration

FDA clearance; BrainSpace; Intellidrop; ICU nursing shortages; brain fluid management; Physical AI; neuro injury

FDA Policy Tracker: 2025 Was a Year of Change

2 weeks ago talkbio0Tagged 2025, Drug Approval, Food Safety, GRAS Reform, Improvements, Mental Recall, Trump administration, United States Food and Drug Administration

FDA; 2025; Trump Administration; Food Safety; FSMA 204; GRAS Reform; Drug Approvals; Recall Improvements

Coloplast announces changes to Executive Leadership Team

4 weeks ago talkbio0Tagged Administration occupational activities, Anthropological Culture, Changing, coloplast, ELT, Executive Leadership Team, Interventional Urology, Johns, Kevin Hardage, Leadership, Persons, Transition Mutation

Coloplast; Executive Leadership Team; ELT changes; Interventional Urology; People & Culture; Kevin Hardage; Tommy Johns; leadership transition; management changes

Hikma announces CEO change and Board appointment

1 month ago talkbio0Tagged * * Riad Mishlawi * *, Board appointment, CEO, Changing, Darwazah, executive leadership, Hikma Pharmaceuticals, Khalid Nabilsi, London

Hikma Pharmaceuticals; CEO change; Riad Mishlawi; Said Darwazah; Khalid Nabilsi; Board appointment; executive leadership; pharmaceuticals; London; 15 December 2025

The Endpoints 100: Biotech CEOs are feeling more upbeat about the road ahead

1 month ago talkbio0Tagged Attitude, biopharma executives, CEOs, dealmaking, E100 survey, Endpoints, Industry, IPO, Market, Recovery - action, reorganization, Sentiment, Trump administration, United States Food and Drug Administration, Window (physical object)

Endpoints 100; E100 survey; biotech CEOs; biopharma executives; industry sentiment; market recovery; dealmaking; IPO window; Trump administration; FDA reorganization; tariffs; 2025 outlook

Enliven Therapeutics Announces New CEO

1 month ago talkbio0Tagged CEO, ELVN, Enliven Therapeutics, Leadership, Myeloid Leukemia, Chronic, Phase 3 trial, Richard Fair, Rick Fair, Transition Mutation

Enliven Therapeutics; ELVN; new CEO; Rick Fair; Richard Fair; Sam Kintz; leadership transition; Phase 3 trial; ELVN-001; chronic myeloid leukemia; CML; biotech; Nasdaq ELVN